In crisis?

Learn

Treatment and buprenorphine

How medication treatment works, and why it starts with a clinician.

What is buprenorphine?

Buprenorphine is an FDA-approved medicine for opioid use disorder. It is a partial opioid agonist, which means it acts on the same receptors as other opioids but with weaker effects. Suboxone is one brand that combines buprenorphine with naloxone.

It can lower cravings and withdrawal symptoms. People treated with methadone or buprenorphine are less likely to die or to have an overdose than people who do not get treatment.

Based on NIDA, MedlinePlus, and SAMHSA. Not yet reviewed by a clinician.

Sources (4)
  1. How do medications to treat opioid use disorder work?
    National Institute on Drug Abuse
  2. Medications for Opioid Use Disorder
    National Institute on Drug Abuse
  3. Buprenorphine Sublingual and Buccal (opioid dependence)
    MedlinePlus, National Library of Medicine
  4. TIP 63: Medications for Opioid Use Disorder
    Substance Abuse and Mental Health Services Administration, 2024-10-11

Where to get it, free and low-cost options first

Buprenorphine can be prescribed by doctors, nurse practitioners, and physician assistants. Opioid treatment programs can also give it. These options can help you find care you can afford.

Based on SAMHSA and HRSA. Not yet reviewed by a clinician.

Sources (4)
  1. TIP 63: Medications for Opioid Use Disorder
    Substance Abuse and Mental Health Services Administration, 2024-10-11
  2. FindTreatment.gov
    Substance Abuse and Mental Health Services Administration
  3. Opioid Treatment Program Directory
    Substance Abuse and Mental Health Services Administration, 2026-01-14
  4. What Is a Health Center?
    Health Resources and Services Administration

Can I get it by telehealth?

Yes. A federal rule that took effect on December 31, 2025 lets DEA-registered clinicians prescribe buprenorphine for opioid use disorder by phone or video for up to six months, with no in-person visit first. After six months, you may need an in-person visit or another approved type of telehealth visit. These rules may change, so ask your provider what applies to you.

Separate, temporary federal telehealth rules for controlled medicines are set to end on December 31, 2026.

Based on the Federal Register. Not yet reviewed by a clinician.

Sources (3)
  1. Expansion of Buprenorphine Treatment via Telemedicine Encounter
    DEA and HHS, Federal Register, 2025-01-17
  2. Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for VA Patients (effective date delay)
    DEA and HHS, Federal Register, 2025-03-24
  3. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications
    DEA and HHS, Federal Register, 2025-12-31

Spot an error? Email support@exitseven.app
Are you a clinician? Help review.